Can You Use Supplements with Semaglutide or Tirzepatide Injections
It mimics GLP-1 hormones responsible for prompting insulin production in the body, which regulates blood sugar
The most common side effects of GLP-1 receptor agonists are gastrointestinal symptoms including nausea, vomiting, diarrhoea, and abdominal discomfort, particularly during treatment initiation
Wegovy is typically prescribed for people who are looking for an effective obesity treatment and is recommended for individuals with a body mass index (BMI) of 27 or higher and who have at least one weight-related condition, such as high blood pressure, Type 2 diabetes, or high cholesterol, according to the drugs Health Canada approval statement
Tirzepatide, another GLP-1 agonist, often results in more weight loss
After 3 doses, its just now starting to work